The RadiCaL study, the first randomized trial of a radiopharmaceutical in kidney cancer, found that adding radium-223 to the standard of care does not improve skeletal event-free survival. Patients who received the combination treatment lived a median of 28.3 months, compared with 19.7 months for those who received cabozantinib alone.
SourceAlliance for Clinical Trials in Oncology·JournalJournal of Clinical Oncology·TypeExperimental study·DateAug 17, 2026
New research at Aston University shows that mānuka honey's effectiveness against disease-causing bacteria cannot be attributed solely to its sugar content and methylglyoxal levels. The study identified additional bioactive compounds responsible for the antimicrobial activity, which may lead to the development of more effective honey-de...
SourceAston University·JournalMicrobiology·TypeExperimental study·DateAug 11, 2026
The Barrow Neurological Institute is conducting a Phase 1/2 clinical trial investigating ibogaine as a therapeutic agent for treating traumatic brain injury (TBI). Researchers aim to enroll 40 participants and determine how effectively ibogaine addresses TBI symptoms and quality of life.
Researchers at the University of Manchester have developed a new family of antifungal agents that are more potent and less toxic than existing treatments. The compounds, which were discovered through genome mining, showed increased antifungal activity and improved solubility compared to existing drugs.
SourceUniversity of Manchester·JournalNature·DateJul 29, 2026
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
The first patient has been enrolled in a global Phase 3 clinical trial evaluating Mocertatug Rezetecan, a novel B7-H4-targeted ADC, in platinum-resistant ovarian cancer. The study aims to determine whether this therapy can improve outcomes compared with standard chemotherapy.
SourceThe GOG Foundation Inc·TypeRandomized controlled/clinical trial·DateJul 27, 2026
A landmark trial shows that children hospitalised with severe pneumonia can recover just as well from injectable to oral antibiotics, even with shorter treatment durations. This simple change could help millions of children worldwide get back to their families sooner and reduce pressure on busy hospitals.
SourceCity St George’s, University of London·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateJul 23, 2026
A clinical trial showed semaglutide improved liver scarring in patients with advanced fatty liver disease and early-stage cirrhosis. Non-invasive blood tests reflected treatment-related improvements more clearly than liver biopsies, which could reduce reliance on invasive procedures.
SourceUniversity of California - San Diego·JournalThe Lancet Gastroenterology & Hepatology·DateJul 16, 2026
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
A buildup of bile acids caused by an unhealthy gut can drive breast cancer to other parts of the body, researchers reveal. The study found that replenishing beneficial bacteria or treating patients with FDA-approved bile acid sequestrants may reduce breast cancer metastasis.
SourceUniversity of Virginia Health System·JournalCancer Research·DateJul 15, 2026
Researchers suggest separate weight-driven tables for different types of defendants, eliminating disparities in crack and methamphetamine sentences. The study proposes alternative approaches to define relative sentences for psychostimulants and opioids based on harms associated with each type of drug.
SourceCarnegie Mellon University·JournalFederal Sentencing Reporter·DateJul 14, 2026
OYE Therapeutics announced positive Phase 1 results for OYE-101, a proprietary intravenous caffeine formulation. The study demonstrated the safety and tolerability of OYE-101 in healthy adult volunteers, supporting its planned development as a treatment to support emergence from general anesthesia and deep sedation.
SourcePurdue University·TypeRandomized controlled/clinical trial·DateJul 14, 2026
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
Researchers discovered a potential drug developed at Michigan Medicine reverses metabolic dysfunction-associated steatohepatitis (MASH) in animal models by disrupting the disease-driving pathway that links the gut and liver. DT-109 improved gut health, reducing inflammation in livers of nonhuman primates.
SourceMichigan Medicine - University of Michigan·JournalJournal of Clinical Investigation·TypeExperimental study·DateJul 7, 2026
The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, have formed a strategic alliance with Bayer to accelerate medical discovery and expand patient access to investigational therapies. Initial focus areas include oncology, cardiovascular disease, and cell and gene therapy.
Researchers will study blood samples and environmental exposures over 10 years to identify genetic, environmental, and cellular factors contributing to autoimmune diseases. The goal is to develop prevention strategies and treatments by understanding the earliest biological triggers of SARDs.
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
A longitudinal study of 21,990 US adults found participants' most intense psychedelic experience on the Fourth of July reported decreased support for partisan violence. In contrast, experiences coinciding with national party conventions or Election Day led to increased support.
SourceSAGE·JournalPsychedelic Medicine·TypeObservational study·DateJul 4, 2026
Researchers at Texas A&M University develop a laser technique called TRIP to directly measure quantum forces shaping proteins, enabling accurate prediction of how pharmaceutical drugs interact with them. This breakthrough could lead to the design of medicines tailored to specific diseases, revolutionizing precision medicine.
SourceTexas A&M University·JournalScience Advances·DateJun 25, 2026
A new oral drug AC01 has been shown to improve heart function and be well-tolerated in patients with chronic heart failure. The study found no serious side effects and suggested potential clinical benefits, warranting further investigation.
SourceKarolinska Institutet·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateJun 24, 2026
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
The US retains its scientific edge but is losing the race to translate discoveries into cures, warns a new report from Cure Innovation Index. Without immediate renewed investment and policy changes, the US scientific edge will not hold.
Researchers found that over-the-counter probiotics contain only 36 unique species of bacteria, with most common species being forms of Lactobacillus. The analysis suggests a lack of consistency in the combination of species used to support gut health and vaginal health claims.
A new clinical trial, SELECTmeso1, is investigating a personalized treatment for patients with a rare and aggressive form of cancer. The trial aims to improve outcomes for patients with a specific genetic biomarker, and if successful, could lead to future practice-changing trials.
SourceUniversity of Leicester·TypeRandomized controlled/clinical trial·DateJun 17, 2026
A new study found that intranasal davunetide reaches the brain in higher amounts in female mice when estrogen peaks, with similar results seen in healthy adults. The findings suggest earlier trials mixing males and females may have obscured the true effects of the drug.
SourceGenomic Press·JournalGenomic Psychiatry·TypeExperimental study·DateJun 16, 2026
The University of Virginia has joined SPARK GLOBAL to leverage resources and expertise in accelerating the development of new medicines. This collaboration aims to reduce time from lab discoveries to clinic trials, delivering tangible healthcare solutions to patients.
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
The NOVO EXPENDITURE trial investigates the effects of a hormone-based treatment on weight loss compared to a reduced-calorie diet. Participants will undergo extensive physiological testing, including metabolic chamber sessions and regular weigh-ins, to assess the treatment's impact on energy use and body weight.
SourcePennington Biomedical Research Center·DateJun 15, 2026
Eighty medical students from across the US and Puerto Rico are selected for a six-week summer experience to introduce them to clinical research early in their careers. The program aims to develop the next generation of clinical investigators equipped to engage communities and improve participation in clinical trials.
SourceThe Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards)·DateJun 11, 2026
Researchers found that temperature and calcium levels inside cells can dramatically impact how drugs interact with their targets. This discovery could lead to smarter medicine design and more effective treatments.
SourceNorthwestern University·JournalNature Structural & Molecular Biology·DateJun 9, 2026
Apple iPad Pro 11-inch (M4)
Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.
A new UTEP study found that patients taking weight loss medications like Ozempic and GLP-1s have a lower risk of developing alcohol, opioid, nicotine, and cocaine use disorders. The study's findings suggest these medications may influence dopamine signaling and other neural pathways involved in cravings.
SourceUniversity of Texas at El Paso·JournalFrontiers in Psychiatry·DateJun 8, 2026
The FLOW trial shows that semaglutide significantly improved health-related quality of life in adults with type 2 diabetes and chronic kidney disease. Health utility scores and self-rated general health scores improved with semaglutide, but declined with placebo.
Researchers have found a widely available drug combination to be an effective treatment for patients with systemically active Sjögren's disease. The combination of leflunomide and hydroxychloroquine reduced disease activity while maintaining a favorable safety profile.
SourceUniversity Medical Center Utrecht·TypeRandomized controlled/clinical trial·DateJun 2, 2026
Researchers have announced promising results of the B-Well clinical trials, showing that 20% and 19% of patients achieved a functional cure for their chronic hepatitis B infections after 24 weeks of bepirovirsen treatment. This represents a significant step towards developing a curative treatment for the disease.
SourceMichigan Medicine - University of Michigan·JournalNew England Journal of Medicine·TypeCommentary/editorial·DateMay 28, 2026
Two projects, BOOST-HP and BIONIC, use machine learning to analyze large datasets of medication exposure and outcomes. The findings highlight the need for more data and cautious design of machine learning models to accurately assess potential links between medications and pregnant women.
SourceJMIR Publications·JournalJournal of Medical Internet Research·TypeCommentary/editorial·DateMay 27, 2026
Apple MacBook Pro 14-inch (M4 Pro)
Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.
After Dobbs v Jackson, US abortion management shifted towards expectant approaches in ban states, with persistent reliance on suboptimal misoprostol-only regimens. State-level abortion bans were associated with a decrease in management options for individuals with spontaneous abortion in ban states.
A national study found a sharp increase in leucovorin prescriptions among children with autism following media coverage and White House promotion. Researchers urge caution due to limited large-scale evidence, highlighting the need for rigorous data to inform treatment decisions.
SourceUniversity of California - San Diego·JournalJAMA Network Open·DateMay 18, 2026
A randomised controlled trial found semaglutide (Wegovy) significantly reduced BMI by 19% and fat mass in young adults with severe obesity, improving metabolic syndrome severity. The study suggests GLP-1 based treatment as a promising option for managing severe obesity in young people resistant to prior hospital-based care.
SourceEuropean Association for the Study of Obesity·DateMay 13, 2026
New research finds that participants in the ATTAIN-MAINTAIN trial maintained a significant percentage of weight loss when switched from injectable tirzepatide or semaglutide to daily oral orforglipron treatment. The study shows that nearly all weight loss achieved on injectable therapies can be maintained by switching to oral therapies.
SourceEuropean Association for the Study of Obesity·JournalNature Medicine·DateMay 12, 2026
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
Patients on tirzepatide at maximum dose have seven times higher odds of maintaining weight loss compared to those who stop treatment. Those on the lower 5mg dose have four times higher odds, according to a new study published in The Lancet.
SourceEuropean Association for the Study of Obesity·JournalThe Lancet·DateMay 12, 2026
Researchers developed genESOM, a generative AI that can expand dataset volume and simulate larger animal numbers while maintaining reliability. This allows for 30-50% reduction in animal experiments without compromising results.
SourceGoethe University Frankfurt·JournalPharmacological Research·TypeComputational simulation/modeling·DateMay 11, 2026
A new post-hoc analysis examined daily oral orforglipron treatment for obesity, with or without diabetes, in users aged 65 years and over. The study found that orforglipron significantly reduced body weight and improved blood sugar markers compared to placebo, with a similar safety profile to the overall ATTAIN clinical trial population.
SourceEuropean Association for the Study of Obesity·DateMay 10, 2026
Rigol DP832 Triple-Output Bench Power Supply
Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.
A pooled analysis of trials reveals semaglutide's safety and efficacy in individuals aged 65 years and older with obesity. The study found significant reductions in body weight and improvements in cardiometabolic risk factors, with a lower proportion of adverse events compared to placebo.
SourceEuropean Association for the Study of Obesity·DateMay 10, 2026
A recent NIH-funded study reveals that oral small-molecule GLP-1 drugs can suppress eating for pleasure and reduce cravings by targeting a deeper brain region, potentially treating other dysfunctions in reward processing. The findings provide insight into the neural mechanisms underlying the effects of these medications.
SourceNIH/Office of the Director·JournalNature·DateMay 6, 2026
The ERASur clinical trial is investigating whether total ablative therapy can improve overall survival in patients with newly diagnosed, limited metastatic colorectal cancer. The study has reached one-third patient accrual milestone, signaling strong momentum.
SourceAlliance for Clinical Trials in Oncology·TypeRandomized controlled/clinical trial·DateMay 6, 2026
The hospital is conducting a phase 2 clinical trial evaluating STAR0602, which activates the immune system to stop tumor growth across various cancers. The goal of this study is to identify safer and more effective treatments for people with advanced cancers.
SourceThe University of Texas at San Antonio Health Science Center·DateApr 15, 2026
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.
The FDA is reviewing a petition to revoke the approval of Roche's top-selling drug ocrelizumab for treating primary progressive multiple sclerosis in women due to concerns over its lack of effectiveness and potential increased risk of breast cancer. The investigation highlights internal FDA warnings about the drug's safety and effectiv...
A phase 2 clinical trial shows that a new drug, elraglusib, when combined with chemotherapy, doubles one-year survival rates in pancreatic cancer patients, reducing the risk of death by 38%. The study is a rare success in showing a survival benefit applicable to a broad population.
SourceNorthwestern University·JournalNature Medicine·DateApr 14, 2026
Scientists at the University of Virginia Health System have developed a suite of AI-powered tools, called YuelDesign, YuelPocket and YuelBond, to transform how new drugs are created. These tools can design drug molecules tailored to fit their protein targets exactly, even accounting for protein flexibility.
SourceUniversity of Virginia Health System·DateApr 9, 2026
Researchers have created a 3D experimental system to study the response of low-grade gliomas to drugs, providing a more realistic environment for testing treatments. The system uses organoids from pluripotent stem cells to replicate glioma development and characteristics.
SourceUniversità di Trento·JournalMolecular Cancer·TypeExperimental study·DateApr 9, 2026
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
A real-world study found that adults taking GLP-1 RAs for weight loss have significantly lower total energy and protein intake. The use of an AI-powered nutritional tracking app revealed that 88% of users were under national protein guidelines, with many skipping meals to reduce protein intake.
SourceEuropean Association for the Study of Obesity·DateApr 9, 2026
A randomized trial found that duloxetine does not prevent painful neuropathy caused by oxaliplatin-based chemotherapy in patients with stage II or III colorectal cancer. The study suggests that duloxetine should only be used for managing existing neuropathy, not prevention.
SourceAlliance for Clinical Trials in Oncology·JournalJCO Oncology Advances·TypeRandomized controlled/clinical trial·DateApr 8, 2026
OYE-101, a novel intravenous caffeine formulation, has been developed to accelerate recovery from general anesthesia and deep sedation. The company's lead program is being evaluated in a scientific bridging study to support a 505(b)(2) NDA for OYE-101.
The Alliance for Clinical Trials in Oncology is enrolling adolescent and young adult cancer patients in various trials, including genetic services and treatment studies. These trials aim to address longstanding gaps in care and improve outcomes for AYAs with cancer.
SourceAlliance for Clinical Trials in Oncology·DateApr 6, 2026
City St George's, University of London, is partnering with Paradigm Biopharmaceuticals to test a potential treatment for osteoarthritis. The partnership aims to investigate the mechanism of action of pentosan polysulfate sodium (iPPS) on bone marrow lesions, which are linked to pain in osteoarthritis.
SourceCity St George’s, University of London·DateApr 1, 2026
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
The Robert A. Winn Excellence in Clinical Trials Award Program has partnered with AstraZeneca to support five medical students participating in the Winn Clinical Investigator Pathway Program (Winn CIPP). The program provides immersive training, mentorship, and hands-on experience to prepare students for careers in clinical research.
SourceThe Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards)·TypeNews article·DateMar 31, 2026
A new study shows that PSMA therapy can delay the need for hormone therapy in prostate cancer patients by an average of 20 months. The therapy is effective in earlier stages of the disease, improving survival and quality of life for approximately two out of three patients.
SourceRadboud University Medical Center·JournalThe Lancet Oncology·TypeRandomized controlled/clinical trial·DateMar 30, 2026
A global clinical trial led by SickKids has found that mavacamten improves blood flow and reduces obstruction in youth with hypertrophic cardiomyopathy (HCM), a genetic heart disease. The study's results offer hope to families avoiding open-heart surgery, setting the stage for precision therapeutics.
SourceThe Hospital for Sick Children·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMar 29, 2026
The phase III Alliance ATOMIC trial shows that adding immunotherapy to standard chemotherapy improves clinical outcomes for patients with stage III dMMR colon cancer. The study found a 50% reduction in cancer recurrence risk and a 86.3% disease-free survival rate at three years.
SourceAlliance for Clinical Trials in Oncology·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMar 25, 2026
A global panel of experts recommends a 10-year trial with 5,000 participants at high risk of cancer due to pre-cursor conditions. The trial will evaluate the potential efficacy of GLP-1 and dual receptor agonists in preventing obesity-related cancers.
SourceEuropean Association for the Study of Obesity·DateMar 25, 2026
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
The Linda and Mike Mussallem Foundation has donated to USC's Keck School of Medicine to enhance clinical trials for individuals with Down syndrome at risk for Alzheimer's. This will increase domestic and international sites, accelerating the development of treatments specifically for this population.
Researchers have developed a low-cost fake drug detector that uses an infrared sensor to track pill dissolution rates. The device can identify legitimate medications from counterfeit ones with high accuracy, making it a valuable tool in the fight against global health threats.
SourceUniversity of California - Riverside·JournalAnalytical Chemistry·DateMar 19, 2026
The Robert A. Winn Excellence in Clinical Trials Award Program is expanding its career development award to include neuropsychiatry researcher-physicians. This expansion aims to improve clinical trial enrollment and represent diverse patient populations affected by complex disorders.
SourceThe Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards)·DateMar 19, 2026
A new clinical trial will investigate whether adding the oral medication vorasidenib to standard chemotherapy improves progression-free survival for people with newly-diagnosed, grade 3 IDH-mutant astrocytoma. The study aims to recruit 400 individuals with this type of brain cancer and evaluate the safety and side-effect profile of the...
SourceAlliance for Clinical Trials in Oncology·DateMar 16, 2026
The NRG-LU005 trial found that immunotherapy atezolizumab did not improve survival for patients with limited-stage small cell lung cancer when added to chemoradiation. Twice-daily radiation therapy, however, was associated with improved survival in this population.
SourceAlliance for Clinical Trials in Oncology·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateMar 12, 2026
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.
A large venous thrombosis trial has found that apixaban is safer than rivaroxaban, with 3.3% of participants experiencing clinically relevant bleeding compared to 7.1% with rivaroxaban. This trial has significant implications for clinical practice and patient care.
SourceThe Ottawa Hospital·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMar 11, 2026